These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 25557742

  • 21. Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.
    Rashidghamat E, Kadiyirire T, Ayis S, Petrof G, Liu L, Pullabhatla V, Ainali C, Guy A, Aristodemou S, McMillan JR, Ozoemena L, Mee J, Pramanik R, Saxena A, Nuamah R, de Rinaldis E, Serrano S, Maurin C, Martinez-Queipo M, Lwin SM, Ilic D, Martinez A, Dazzi F, Slaper-Cortenbach I, Westinga K, Zeddies S, van den Broek M, Onoufriadis A, Mellerio JE, McGrath JA.
    J Am Acad Dermatol; 2020 Aug; 83(2):447-454. PubMed ID: 31786163
    [Abstract] [Full Text] [Related]

  • 22. Case report: rapidly healing epidermolysis bullosa wound after ablative fractional resurfacing.
    Krakowski AC, Ghasri P.
    Pediatrics; 2015 Jan; 135(1):e207-10. PubMed ID: 25535263
    [Abstract] [Full Text] [Related]

  • 23. Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases.
    Hasegawa T, Mizoguchi M, Haruna K, Mizuno Y, Muramatsu S, Suga Y, Ogawa H, Ikeda S.
    J Dermatol; 2007 May; 34(5):328-32. PubMed ID: 17408442
    [Abstract] [Full Text] [Related]

  • 24. ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa.
    Dieter K, Niebergall-Roth E, Daniele C, Fluhr S, Frank NY, Ganss C, Kiritsi D, McGrath JA, Tolar J, Frank MH, Kluth MA.
    Cytotherapy; 2023 Jul; 25(7):782-788. PubMed ID: 36868990
    [Abstract] [Full Text] [Related]

  • 25. Aberrant recruitment of leukocytes defines poor wound healing in patients with recessive dystrophic epidermolysis bullosa.
    Phillips T, Huitema L, Cepeda R, Cobos DL, Perez RIM, Garza MS, Ringpfeil F, Dasgeb B, Uitto J, Salas-Alanis JC, Alexeev V, Igoucheva O.
    J Dermatol Sci; 2020 Dec; 100(3):209-216. PubMed ID: 33143962
    [Abstract] [Full Text] [Related]

  • 26. Cultured allogeneic fibroblast injection vs. fibroblasts cultured on amniotic membrane scaffold for dystrophic epidermolysis bullosa treatment.
    Moravvej H, Abdollahimajd F, Naseh MH, Piravar Z, Abolhasani E, Mozafari N, Niknejad H.
    Br J Dermatol; 2018 Jul; 179(1):72-79. PubMed ID: 29330848
    [Abstract] [Full Text] [Related]

  • 27. Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa.
    Niebergall-Roth E, Dieter K, Daniele C, Fluhr S, Khokhrina M, Silva I, Ganss C, Frank MH, Kluth MA.
    Cells; 2023 May 24; 12(11):. PubMed ID: 37296590
    [Abstract] [Full Text] [Related]

  • 28. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa.
    Alexeev V, Donahue A, Uitto J, Igoucheva O.
    Stem Cell Res Ther; 2016 Aug 27; 7(1):124. PubMed ID: 27568180
    [Abstract] [Full Text] [Related]

  • 29. Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa.
    Liao Y, Itoh M, Yang A, Zhu H, Roberts S, Highet AM, Latshaw S, Mitchell K, van de Ven C, Christiano A, Cairo MS.
    Cell Transplant; 2014 Mar 27; 23(3):303-17. PubMed ID: 23394106
    [Abstract] [Full Text] [Related]

  • 30. Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa.
    Yan WF, Murrell DF.
    Dermatol Clin; 2010 Apr 27; 28(2):367-70, xii. PubMed ID: 20447505
    [Abstract] [Full Text] [Related]

  • 31. Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review.
    Li AW, Prindaville B, Bateman ST, Gibson TE, Wiss K.
    Pediatr Dermatol; 2017 Nov 27; 34(6):647-655. PubMed ID: 28944966
    [Abstract] [Full Text] [Related]

  • 32. Using honey to heal a chronic wound in a patient with epidermolysis bullosa.
    Hon J.
    Br J Nurs; 2017 Nov 27; 14(19):S4-5, S8, S10 passim. PubMed ID: 16315361
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of a bovine 100% native collagen for the treatment of chronic wounds: a case series.
    Shah SV, Chakravarthy D.
    J Wound Ostomy Continence Nurs; 2015 Nov 27; 42(3):226-34. PubMed ID: 25945821
    [Abstract] [Full Text] [Related]

  • 34. Cultured Epidermal Autografts from Clinically Revertant Skin as a Potential Wound Treatment for Recessive Dystrophic Epidermolysis Bullosa.
    Matsumura W, Fujita Y, Shinkuma S, Suzuki S, Yokoshiki S, Goto H, Hayashi H, Ono K, Inoie M, Takashima S, Nakayama C, Nomura T, Nakamura H, Abe R, Sato N, Shimizu H.
    J Invest Dermatol; 2019 Oct 27; 139(10):2115-2124.e11. PubMed ID: 31054844
    [Abstract] [Full Text] [Related]

  • 35. Dystrophic calcinosis cutis in autosomal recessive dystrophic epidermolysis bullosa.
    Bhari N, Bharti P.
    BMJ Case Rep; 2019 Sep 20; 12(9):. PubMed ID: 31540927
    [Abstract] [Full Text] [Related]

  • 36. The clinical efficacy and safety of anti-IgE therapy in recessive dystrophic epidermolysis bullosa.
    Chen F, Guo Y, Zhou K, Deng D, Yue W, Yang W, Zhang B, Li Y, Liang J, Li M, Yao Z.
    Clin Genet; 2022 Jan 20; 101(1):110-115. PubMed ID: 34494659
    [Abstract] [Full Text] [Related]

  • 37. State-of-the-art wound healing: skin substitutes for chronic wounds.
    Han G.
    Cutis; 2014 Jan 20; 93(1):E13-6. PubMed ID: 24505591
    [Abstract] [Full Text] [Related]

  • 38. Pseudosyndactyly - an inflammatory and fibrotic wound healing disorder in recessive dystrophic epidermolysis bullosa.
    Breitenbach J, Gruber C, Klausegger A, Trost A, Bogner B, Reitsamer H, Bauer JW.
    J Dtsch Dermatol Ges; 2015 Dec 20; 13(12):1257-66. PubMed ID: 26612796
    [Abstract] [Full Text] [Related]

  • 39. Gene therapy for recessive dystrophic epidermolysis bullosa.
    Titeux M, Pendaries V, Hovnanian A.
    Dermatol Clin; 2010 Apr 20; 28(2):361-6, xii. PubMed ID: 20447504
    [Abstract] [Full Text] [Related]

  • 40. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
    Fuentes I, Yubero MJ, Morandé P, Varela C, Oróstica K, Acevedo F, Rebolledo-Jaramillo B, Arancibia E, Porte L, Palisson F.
    Int Wound J; 2023 Mar 20; 20(3):774-783. PubMed ID: 36787273
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.